Transcriptomics

Dataset Information

0

A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis


ABSTRACT: A phase 2, double-blind, placebo-controlled trial evaluated apremilast efficacy, safety, and pharmacodynamics in adults with moderate to severe atopic dermatitis (AD).

ORGANISM(S): Homo sapiens

PROVIDER: GSE120899 | GEO | 2018/10/06

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-11-12 | GSE141570 | GEO
2019-06-29 | GSE133477 | GEO
2020-09-01 | GSE137430 | GEO
2019-05-02 | GSE130588 | GEO
2012-06-01 | E-MTAB-728 | biostudies-arrayexpress
2023-06-24 | GSE182740 | GEO
| PRJNA551580 | ENA
2023-11-28 | GSE214503 | GEO
| PRJNA714989 | ENA
2019-09-11 | E-MTAB-8149 | biostudies-arrayexpress